The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
April 6, 2020
Table: Treatments Considered for COVID-19 (Archived) (online only)
Download PDF: US English
Med Lett Drugs Ther. 2020 Apr 6;62(1595):e1-289
Disclosures
Principal Faculty- Mark Abramowicz, M.D., President: no disclosure or potential conflict of interest to report
- Jean-Marie Pflomm, Pharm.D., Editor in Chief: no disclosure or potential conflict of interest to report
- Brinda M. Shah, Pharm.D., Consulting Editor: no disclosure or potential conflict of interest to report
- F. Peter Swanson, M.D., Consulting Editor: no disclosure or potential conflict of interest to report
Objective(s)
Upon completion of this activity, the participant will be able to:
- Discuss the role of available and investigational drugs in the management of COVID-19.
Archived; last update: April 1, 2022
View the Table: Treatments Considered for COVID-19
Download PDF: US English
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.